Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05957523 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT)

Study acronym: EMINENT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 3 to 1v4 Show 6 more changesShow less
    • Enrollment target: 60 to 80
    • Primary completion date changed from estimate of Dec 12, 2024 to Oct 23, 2024
    • Study completion date: Dec 12, 2025 to Oct 31, 2026
    • Secondary endpoints: 4 to 5
    • Study description expanded, about 89 words
    • Study arms: 2 to 3
  2. Trial status: Not Yet Recruiting to Recruitingv3 Show 9 more changesShow less
    • Enrollment target: 40 to 60
    • Study completion date: Dec 12, 2024 to Dec 12, 2025
    • Start date changed from estimate of May 20, 2024 to Jun 27, 2024
    • Eligibility criteria expanded, about 42 words
    • Secondary endpoints: 5 to 4
    • Study description expanded, about 42 words
    • Site details revised
    • Study arms: 1 to 2
    • Study title shortened, about 1 word
  3. Primary completion date: Oct 12, 2023 to Dec 12, 2024v2 Show 7 more changesShow less
    • Start date: Sep 30, 2023 to May 20, 2024
    • Primary endpoints: 1 to 3
    • Enrollment target: 50 to 40
    • Study completion date: Dec 12, 2023 to Dec 12, 2024
    • Secondary endpoints: details revised at 2 of 5 entries
    • Study description expanded, about 30 words
    • Study title expanded, about 3 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to investigate the effects of remote ischaemic preconditioning on the peripheral blood characteristics of healthy adults and to explore the possible mechanisms for improving ischaemia/reperfusion injury and its protective effects on the cardiovascular system.
Trial Details
NCT Number NCT05957523
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Conditions
(from sponsor)		 Ischemic Preconditioning
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov